Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2000 | 03-2000 | 12-1999 | 09-1999 | 06-1999 | |
| Sales | 1,038 | 620 | 438 | 1,387 | 645 |
| Gross Profit | 1,030 | 620 | 460 | 1,380 | 640 |
| Operating Expenses | 9,840 | 7,060 | 7,390 | 7,560 | 4,870 |
| Operating Income | -8,802 | -6,440 | -6,952 | -6,173 | -4,225 |
| Interest Expense | 0 | 0 | 30 | 0 | 0 |
| Other Income | 2 | -20 | 32 | -17 | -15 |
| Pre-tax Income | -8,800 | -6,460 | -6,950 | -6,190 | -4,240 |
| Income Tax | 0 | 0 | 10 | 0 | 0 |
| Net Income Continuous | -8,813 | -6,464 | -7,001 | -6,204 | -4,229 |
| Net Income | $-8,813 | $-6,464 | $-7,001 | $-6,204 | $-4,229 |
| EPS Basic Total Ops | -6.84 | -5.04 | -5.76 | -5.04 | -3.24 |
| EPS Basic Continuous Ops | -6.69 | -5.02 | -5.65 | -5.09 | -3.24 |
| EPS Diluted Total Ops | -6.84 | -5.04 | -5.76 | -5.04 | -3.24 |
| EPS Diluted Continuous Ops | -6.69 | -5.02 | -5.65 | -5.09 | -3.24 |
| EBITDA(a) | $-8,572 | $-6,210 | $-6,892 | $-5,973 | $-3,985 |